{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:50:24Z","timestamp":1773939024615,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7254398"],"award-info":[{"award-number":["7254398"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008235","name":"Peking Union Medical College Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023-I2M-2\\u2013002"],"award-info":[{"award-number":["2023-I2M-2\\u2013002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejca.2025.116159","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T16:02:15Z","timestamp":1764432135000},"page":"116159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Quantitative spatial profiling of PD-1\/PD-L1 and TIGIT\/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma"],"prefix":"10.1016","volume":"232","author":[{"given":"Xianlong","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanyue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangni","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9191-2521","authenticated-orcid":false,"given":"Xinyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib1","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00423-010-0677-3","article-title":"Clinicopathological features of adenosquamous pancreatic cancer","volume":"396","author":"Regi","year":"2011","journal-title":"Lange Arch Surg"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jss.2011.06.015","article-title":"415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival","volume":"174","author":"Boyd","year":"2012","journal-title":"J Surg Res"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jso.25112","article-title":"Comparative outcomes of adenosquamous carcinoma of the pancreas: an analysis of the National Cancer Database","volume":"118","author":"Hester","year":"2018","journal-title":"J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MPA.0000000000000089","article-title":"Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study","volume":"43","author":"Imaoka","year":"2014","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.ejca.2025.116159_bib6","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.ejso.2019.05.011","article-title":"Survival and prognostic factors in patients with pancreatic squamous cell carcinoma","volume":"45","author":"Tella","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"21","key":"10.1016\/j.ejca.2025.116159_bib7","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1200\/JCO.2007.15.8469","article-title":"Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital","volume":"26","author":"Herman","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejca.2025.116159_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/j.ejca.2025.116159_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010124","article-title":"Pancreatic cancer is feeling the heat","volume":"12","author":"Maru","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12951-023-01966-4","article-title":"Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy","volume":"21","author":"Liu","year":"2023","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"10.1016\/j.ejca.2025.116159_bib11","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ccell.2020.08.004","article-title":"Challenges and Opportunities for Pancreatic Cancer Immunotherapy","volume":"38","author":"Bear","year":"2020","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.ejca.2025.116159_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007586","article-title":"Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma","volume":"11","author":"Katz","year":"2023","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1470-2045(24)00679-X","article-title":"Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b-2, study","volume":"26","author":"Finn","year":"2025","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ni.1674","article-title":"The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells","volume":"10","author":"Yu","year":"2009","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2016.10.002","article-title":"TIGIT: A Key Inhibitor of the Cancer Immunity Cycle","volume":"38","author":"Manieri","year":"2017","journal-title":"Trends Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188483","article-title":"Of immune checkpoint maladies and remedies: The throwing of jabs in the oncogenic ring of PDAC","volume":"1875","author":"Olaoba","year":"2021","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054406","article-title":"Toll-like receptor ligands induce expression of the costimulatory molecule CD155 on antigen-presenting cells","volume":"8","author":"Kamran","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejca.2025.116159_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003134","article-title":"TIGIT\/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment","volume":"9","author":"Kawashima","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"13","key":"10.1016\/j.ejca.2025.116159_bib19","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.7150\/thno.86547","article-title":"The spatial coexistence of TIGIT\/CD155 defines poorer survival and resistance to adjuvant chemotherapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Ma","year":"2023","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.ejca.2025.116159_bib20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","article-title":"The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function","volume":"26","author":"Johnston","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1158\/1078-0432.CCR-21-2649","article-title":"Association of PD-1\/PD-L1 Co-location with Immunotherapy Outcomes in Non-Small Cell Lung Cancer","volume":"28","author":"Gavrielatou","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"21","key":"10.1016\/j.ejca.2025.116159_bib22","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1158\/1078-0432.CCR-18-0309","article-title":"Quantitative Spatial Profiling of PD-1\/PD-L1 Interaction and HLA-DR\/IDO-1 Predicts Improved Outcomes of Anti-PD-1 Therapies in Metastatic Melanoma","volume":"24","author":"Johnson","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2025.116159_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-1-60761-806-5_15","article-title":"Automated analysis of tissue microarrays","volume":"664","author":"Dolled-Filhart","year":"2010","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.ejca.2025.116159_bib24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PD-L1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.116159_bib26","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1053\/j.gastro.2015.04.010","article-title":"Exclusion of T cells from pancreatic carcinomas in mice is regulated by Ly6C(low) F4\/80(+) extratumoral macrophages","volume":"149","author":"Beatty","year":"2015","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.ejca.2025.116159_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.ccell.2021.07.007","article-title":"The CD155\/TIGIT axis promotes and maintains immune evasion in neoantigen-expressing pancreatic cancer","volume":"39","author":"Freed-Pastor","year":"2021","journal-title":"Cancer Cell"},{"issue":"6332","key":"10.1016\/j.ejca.2025.116159_bib29","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.aaf1292","article-title":"T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition","volume":"355","author":"Hui","year":"2017","journal-title":"Science"},{"issue":"1-2","key":"10.1016\/j.ejca.2025.116159_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellimm.2012.07.001","article-title":"Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors","volume":"278","author":"Park","year":"2012","journal-title":"Cell Immunol"},{"issue":"17","key":"10.1016\/j.ejca.2025.116159_bib31","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1073\/pnas.1003345107","article-title":"Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer","volume":"107","author":"Matsuzaki","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.ejca.2025.116159_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.15386\/mpr-2116","article-title":"PD-1\/PD-L1 expression in pancreatic cancer and its implication in novel therapies","volume":"94","author":"Mucileanu","year":"2021","journal-title":"Med Pharm Rep"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","article-title":"Transcriptional regulatory network for the establishment of CD8(+) T cell exhaustion","volume":"53","author":"Seo","year":"2021","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/j.ejca.2025.116159_bib34","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.dld.2019.03.015","article-title":"Contrast-enhanced harmonic endoscopic ultrasonography for evaluating the response to chemotherapy in pancreatic cancer","volume":"51","author":"Tanaka","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.ejca.2025.116159_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ejca.2025.116159_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nm.2999","article-title":"Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth","volume":"19","author":"Bruchard","year":"2013","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ejca.2025.116159_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.it.2015.02.006","article-title":"Immune-mediated mechanisms influencing the efficacy of anticancer therapies","volume":"36","author":"Coffelt","year":"2015","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.ejca.2025.116159_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000978","article-title":"Intratumoral TIGIT(+) CD8(+) T-cell infiltration determines poor prognosis and immune evasion in patients with muscle-invasive bladder cancer","volume":"8","author":"Liu","year":"2020","journal-title":"J Immunother Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925010457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:11:54Z","timestamp":1773875514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925010457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"alternative-id":["S0959804925010457"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116159","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative spatial profiling of PD-1\/PD-L1 and TIGIT\/CD155 interaction indicates poor survival outcome and resistance to adjuvant chemotherapy in pancreatic adenosquamous carcinoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.116159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116159"}}